Anti-TNF-α in the treatment of non-infectious uveitis

被引：3

作者：

Hoogewoud, Florence ^{[1
,2
]}

Kowalczuk, Laura ^{[2
,3
]}

Bousquet, Elodie ^{[1
,3
]}

Brezin, Antoine ^{[1
,3
]}

Touchard, Elodie ^{[4
]}

Buggage, Ronald ^{[4
]}

Bordet, Thierry ^{[4
]}

Behar-Cohen, Francine ^{[1
,3
]}

机构：

[1] Univ Paris, Ophtalmopole Hop Cochin, Assistance Publ Fopitaux Paris, 27 Rue Faubourg St Jacques, F-75014 Paris, France

[2] Univ Lausanne, Dept Ophtalmol, Hop Ophtalmol Jules Gonin, Lausanne, Switzerland

[3] Univ Paris, Inserm UMR 1138, Physiopathol Malad Oculaires Innovat Therapeut, Ctr Rech Cordeliers, 15 Rue Ecole Med, F-75006 Paris, France

[4] Eyevensys SAS, Paris, France

来源：

M S-MEDECINE SCIENCES | 2020年 / 36卷 / 10期

关键词：

TUMOR-NECROSIS-FACTOR; LONG-TERM EFFICACY; ANTERIOR UVEITIS; ELECTROTRANSFER; ADALIMUMAB; INFLIXIMAB; DELIVERY; PRINCIPLES; THERAPY; FLARES;

D O I：

10.1051/medsci/2020160

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Non-infectious uveitis is a heterogenous group of potentially blinding ocular autoimmune diseases that may represent a manifestation of a systemic condition or may affect the eyes only. A systemically administered anti-TNF has recently been approved for the treatment of non-infectious uveitis, broadening the therapeutic arsenal available to control intraocular inflammation and reduce uveitis complications that can lead to vision loss. When uveitis affects only the eyes, a local anti-TNF-alpha administration strategy could optimize the ocular therapeutic effect and reduce undesirable systemic side-effects. A new ocular method of non-viral gene therapy, currently in development, may broaden the indications for ocular anti-TNF-alpha agents, not only for uveitis but also for other diseases in which TNF-alpha-mediated neuro-inflammation has been demonstrated.

引用

页码：893 / 899

页数：7

共 50 条

[41] Cytokines and Biologics in non-infectious autoimmune uveitis: Bench to Bedside
Agrawal, Rupesh
Iyer, Jayant
Connolly, John
Iwata, Daiju
Teoh, Stephen
INDIAN JOURNAL OF OPHTHALMOLOGY, 2014, 62 (01) : 74 - 81
[42] Chronic Non-infectious Uveitis in Patients with Juvenile Idiopathic Arthritis
Kolomeyer, Anton M.
Tu, Yufei
Miserocchi, Elisabetta
Ranjan, Mangala
Davidow, Amy
Chu, David S.
OCULAR IMMUNOLOGY AND INFLAMMATION, 2016, 24 (04) : 377 - 385
[43] Review of the latest systemic treatments for chronic non-infectious uveitis
Kheir, Valeria
Vaudaux, Jean
Guex-Crosier, Yan
EXPERT REVIEW OF OPHTHALMOLOGY, 2016, 11 (02) : 111 - 133
[44] Non-anti-TNF biologic modifier drugs in non-infectious refractory chronic uveitis: The current evidence from a systematic review
Simonini, Gabriele
Cimaz, Rolando
Jones, Gareth T.
Macfarlane, Gary J.
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2015, 45 (02) : 238 - 250
[45] Non-infectious Chronic Uveitis in Childhood: Assessment and Treatment in the Biological Era
Roberta Ponti
Maria Vincenza Mastrolia
Gabriele Simonini
Current Treatment Options in Rheumatology, 2021, 7 : 82 - 97
[46] New Pharmacological Strategies for the Treatment of Non-Infectious Uveitis. A Minireview
Valenzuela, Rodrigo A.
Flores, Ivan
Urrutia, Beatriz
Fuentes, Francisca
Sabat, Pablo E.
Llanos, Carolina
Cuitino, Loreto
Urzua, Cristhian A.
FRONTIERS IN PHARMACOLOGY, 2020, 11
[47] Non-Infectious Uveitis: Optimising the Therapeutic Response
Archana Airody
Greg Heath
Susan Lightman
Richard Gale
Drugs, 2016, 76 : 27 - 39
[48] Efficacy of Biosimilar Infliximab-Dyyb in Non-Infectious Uveitis
Zaguia, Fatma
Randerson, Edward L.
Moorthy, Ramana S.
Goldstein, Debra A.
OCULAR IMMUNOLOGY AND INFLAMMATION, 2024, 32 (08) : 1517 - 1521
[49] Anti-TNF-α agents in the treatment of psoriatic arthritis
Brandt, J
Braun, J
EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (02) : 99 - 107
[50] Therapeutic Concepts for Treatment of Patients with Non-infectious Uveitis Biologic Disease Modifying Antirheumatic Drugs
Walscheid, Karoline
Pleyer, Uwe
Heiligenhaus, Arnd
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2018, 235 (05) : 553 - 561

← 1 2 3 4 5 →